BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2012
View Archived Issues
New interferon-free therapy for hepatitis C is active in INFORM-SVR trial
Read More
AstraZeneca offers overview of first quarter 2012
Read More
Genentech presents first small-molecule Ras inhibitors
Read More
Apricus Biosciences to meet with Health Canada on Femprox
Read More
Exonhit describes novel tubulin polymerization inhibitor
Read More
Double-blind trial assesses secukinumab for psoriatic arthritis
Read More
Researchers in Taiwan identify new candidate biomarker of kidney injury
Read More
Agreement set for development of etanercept and rituximab biosimilars
Read More
Generon begins phase II trial of F-627
Read More
Mayo Clinic to conduct phase I trials on HER2/Neu antigens
Read More
New ALS research partnership launched
Read More
Pozen licenses novel migraine therapy to Desitin in Europe
Read More
OPKO Health out-licenses prostate cancer biomarker panel
Read More
Kineta and collaborators receive biodefense grant
Read More
Genta begins phase II trial of tesetaxel in gastric cancer
Read More
Roche submits application for anticancer drug in Australia
Read More
FDA advisory committee votes on new indication for Arcalyst
Read More
Japanese authorities lift approval condition and extend label for Remicade
Read More
FDA provides update on Revlimid
Read More
GTx gives update on Capesaris IND
Read More
Rexahn Pharmaceuticals submits ovarian cancer study protocol to FDA
Read More
Ten more European countries recommend approval of Sativex
Read More
Boehringer Ingelheim develops new candidate hepatitis therapies
Read More
New PI3K inhibitors discovered at Millennium Pharmaceuticals
Read More
NoNO divulges novel peptides with therapeutic potential
Read More
